-
Notifications
You must be signed in to change notification settings - Fork 0
New issue
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.
By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.
Already on GitHub? Sign in to your account
Assign categorical Lazarin 2014 Tiers #4
Comments
So after rereading Lazarin 2014, my understanding of Tiers is a bit different. Basically clinical characteristic can be assigned tiers (1-4). The tiers are then mapped onto severity categories (Mild, Moderate, Severe, Profound) like so: So perhaps it would make more sense to map our phenotypes onto these severity categories instead of the tiers |
Lazarin 2014 also struggled with the same ambiguity we're facing regarding the role of available treatments:
One thing we do improve upon over Lazarin is the issue of "expressivity". We basically capture a rough approximation of this with the never/rarely/often/always classifications. |
Good spot, hadn’t noted that flow chart before.
Makes sense to use their system (maybe with ranking within e.g. profound, based on how many other tier 1 or 2 there are,
I agree with this:
tiers_dict <- list(
## Tier 1
death=1,
intellectual_disability=1,
## Tier 2
impaired_mobility=2,
physical_malformations=2,
## Tier 3
blindness=3,
sensory_impairments=3,
immunodeficiency=3,
cancer=3,
## Tier 4
reduced_fertility=4
)
From: Brian M. Schilder ***@***.***>
Date: Tuesday, 14 May 2024 at 11:29
To: neurogenomics/gpt_hpo_annotations ***@***.***>
Cc: Skene, Nathan G ***@***.***>, Mention ***@***.***>
Subject: Re: [neurogenomics/gpt_hpo_annotations] Assign categorical Lazarin 2014 Tiers (Issue #4)
This email from ***@***.*** originates from outside Imperial. Do not click on links and attachments unless you recognise the sender. If you trust the sender, add them to your safe senders list<https://spam.ic.ac.uk/SpamConsole/Senders.aspx> to disable email stamping for this address.
Mapping our metrics onto Tiers is a bit challenging since they're quite different:
(from Table 1 on Lazarin 2014)
image.png (view on web)<https://github.com/neurogenomics/gpt_hpo_annotations/assets/34280215/e93dafb7-7e9d-4f8b-9aae-9011d6711312>
Here's my closest approximation. Notable issues:
* Our metric "congenital onset" doesn't directly map onto any of the Lazarin criterion. Something can be congenital and not necessarily cause death at an early age.
* Our metric "physical malformation" maps onto multiple Lazarin criteria; internal physical malformation (Tier 2), and dysmorphic features (Tier 3). We currently can't distinguish between these two situations, where internal malformations are more likely to be severe since they affect organ systems. Assigning our "physical malformation" onto Tier 2 only for now.
tiers_dict <- list(
## Tier 1
death=1,
intellectual_disability=1,
## Tier 2
impaired_mobility=2,
physical_malformations=2,
## Tier 3
blindness=3,
sensory_impairments=3,
immunodeficiency=3,
cancer=3,
## Tier 4
reduced_fertility=4
)
—
Reply to this email directly, view it on GitHub<#4 (comment)>, or unsubscribe<https://github.com/notifications/unsubscribe-auth/AH5ZPE2CQLVLMRSSWSRCQEDZCHRSBAVCNFSM6AAAAABGJPYC62VHI2DSMVQWIX3LMV43OSLTON2WKQ3PNVWWK3TUHMZDCMBZHA2DINBVG4>.
You are receiving this because you were mentioned.Message ID: ***@***.***>
|
Now described in Results and Methods under new section " Severity classes". Added the violin plot to the supp as well. |
@NathanSkene suggested we should use the Lazarin 2014 Tier system. But I pointed out that the reason we switched to a continuous severity score is because it provides a quantitative way of sorting the phenotypes. Also, we don't exactly recapitulate the Lazarin criteria with the GPT annotations, it's more like we were inspired by Lazarin 2014 to generate some our own somewhat similar criteria.
One mid-ground might be to create a rule-based function that attempts to approximate the Lazarin 2014 Tiers. It won't be exactly the same, but it might be useful for grouping our phenotypes into discrete severity categories.
The text was updated successfully, but these errors were encountered: